Deyue G. Yan

800 Dongchuan Road
Shanghai, 200240, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 118 publications

Self-assembly of DOPA-containing peptides for enhanced antimicrobial efficacy and promoted wound healing.

Self-assembly of DOPA-containing peptides for enhanced antimicrobial efficacy and promoted wound healing.

Journal: Biomaterials science

Published: July 27, 2026

A smart P-gp inhibitor-drug conjugate nanomedicine overcomes administration challenges and multidrug resistance in breast cancer therapy.

A smart P-gp inhibitor-drug conjugate nanomedicine overcomes administration challenges and multidrug resistance in breast cancer therapy.

Journal: Biomaterials science

Published: March 30, 2026

Accelerating SuFEx Reactions via Aryl Fluorosulfate Structural Engineering for Enhanced Covalent Targeted Cancer Therapy.

Accelerating SuFEx Reactions via Aryl Fluorosulfate Structural Engineering for Enhanced Covalent Targeted Cancer Therapy.

Journal: Angewandte Chemie (International ed. in English)

Published: February 11, 2026

A charge-reversal prodrug activated by tumor-acidity for selective cancer chemotherapy.

A charge-reversal prodrug activated by tumor-acidity for selective cancer chemotherapy.

Journal: Biomaterials science

Published: January 19, 2026

A Nanodrug Self-Assembled from a Redox-Responsive Cabazitaxel-Zosuquidar Conjugate and DSPE-PEG2k Reverses Multidrug Resistance in Nonsmall Cell Lung Cancer.

A Nanodrug Self-Assembled from a Redox-Responsive Cabazitaxel-Zosuquidar Conjugate and DSPE-PEG2k Reverses Multidrug Resistance in Nonsmall Cell Lung Cancer.

Journal: ACS applied bio materials

Published: September 03, 2025

Synergistic SuFEx-Driven Covalent Cancer Therapy Using a HER2/EGFR Bivalent Affinity Protein Drug.

Synergistic SuFEx-Driven Covalent Cancer Therapy Using a HER2/EGFR Bivalent Affinity Protein Drug.

Journal: Angewandte Chemie (International ed. in English)

Published: August 05, 2025

Wearing bacteriophages individually with an adhesive drug-loadable nanohelmet for treating ocular infections.

Wearing bacteriophages individually with an adhesive drug-loadable nanohelmet for treating ocular infections.

Journal: Science advances

Published: July 11, 2025

Covalent Affibody-Molecular Glue Drug Conjugate Nanoagent for Proximity-Enabled Reactive Therapeutics.

Covalent Affibody-Molecular Glue Drug Conjugate Nanoagent for Proximity-Enabled Reactive Therapeutics.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 02, 2024

Affibody-Functionalized Elastin-like Peptide-Drug Conjugate Nanomicelle for Targeted Ovarian Cancer Therapy.

Affibody-Functionalized Elastin-like Peptide-Drug Conjugate Nanomicelle for Targeted Ovarian Cancer Therapy.

Journal: Biomacromolecules

Published: September 05, 2024

Iridium-Catalyzed Asymmetric Hydroarylation of Unactivated Alkenes with Heterobiaryls: Simultaneous Construction of Axial and Central Chirality.

Iridium-Catalyzed Asymmetric Hydroarylation of Unactivated Alkenes with Heterobiaryls: Simultaneous Construction of Axial and Central Chirality.

Journal: Organic letters

Published: August 07, 2024

PbsNRs: predict the potential binders and scaffolds for nuclear receptors.

PbsNRs: predict the potential binders and scaffolds for nuclear receptors.

Journal: Briefings in bioinformatics

Published: July 24, 2024

A novel HER2 targeting nanoagent self-assembled from affibody-epothilone B conjugate for cancer therapy.

A novel HER2 targeting nanoagent self-assembled from affibody-epothilone B conjugate for cancer therapy.

Journal: Journal of nanobiotechnology

Published: June 13, 2024

Showing 1-12 of 118

Last Updated: 09/26/2026